Sign up to access all valuation multiples
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
2018
127
Last FY Revenue $179M
Last FY EBITDA $31.8M
$276M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Eurobio Scientific reported revenue of $179M and EBITDA of $31.8M.
Eurobio Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Eurobio Scientific valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $179M | XXX | XXX | XXX |
| Gross Profit | XXX | $82.8M | XXX | XXX | XXX |
| Gross Margin | XXX | 46% | XXX | XXX | XXX |
| EBITDA | XXX | $31.8M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 18% | XXX | XXX | XXX |
| EBIT | XXX | $11.3M | XXX | XXX | XXX |
| EBIT Margin | XXX | 6% | XXX | XXX | XXX |
| Net Profit | XXX | $4.6M | XXX | XXX | XXX |
| Net Margin | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eurobio Scientific has current market cap of EUR 249M (or $288M), and EV of EUR 239M (or $276M).
As of October 17, 2025, Eurobio Scientific's stock price is EUR 25 (or $29).
See Eurobio Scientific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $276M | $288M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialEurobio Scientific's trades at 1.5x EV/Revenue multiple, and 8.7x EV/EBITDA.
See valuation multiples for Eurobio Scientific and 15K+ public compsAs of October 17, 2025, Eurobio Scientific has market cap of $288M and EV of $276M.
Equity research analysts estimate Eurobio Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eurobio Scientific's P/E ratio is not available.
| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $288M | XXX | $288M | XXX | XXX | XXX |
| EV (current) | $276M | XXX | $276M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 8.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 24.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 62.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 17.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEurobio Scientific's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.6M for the same period.
Eurobio Scientific's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurobio Scientific's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Eurobio Scientific and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| ALS | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eurobio Scientific acquired XXX companies to date.
Last acquisition by Eurobio Scientific was XXXXXXXX, XXXXX XXXXX XXXXXX . Eurobio Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Eurobio Scientific founded? | Eurobio Scientific was founded in 2018. |
| Where is Eurobio Scientific headquartered? | Eurobio Scientific is headquartered in France. |
| How many employees does Eurobio Scientific have? | As of today, Eurobio Scientific has 127 employees. |
| Is Eurobio Scientific publicy listed? | Yes, Eurobio Scientific is a public company listed on PAR. |
| What is the stock symbol of Eurobio Scientific? | Eurobio Scientific trades under ALERS ticker. |
| When did Eurobio Scientific go public? | Eurobio Scientific went public in 2005. |
| Who are competitors of Eurobio Scientific? | Similar companies to Eurobio Scientific include e.g. Australian Clinical Labs, ALS, Healius, Integral Diagnostics. |
| What is the current market cap of Eurobio Scientific? | Eurobio Scientific's current market cap is $288M |
| Is Eurobio Scientific profitable? | Yes, Eurobio Scientific is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
